✦ LIBER ✦

Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer

✍ Scribed by Jeffrey A. Meyerhardt; Jeffrey W. Clark; Jeffrey G. Supko; Joseph P. Eder; Shuji Ogino; Clinton F. Stewart; Ferdinando D’Amato; Janet Dancey; Peter C. Enzinger; Andrew X. Zhu; David P. Ryan; Craig C. Earle; Robert J. Mayer; Ann Michelini; Kate Kinsella; Charles S. Fuchs

Publisher: Springer
Year: 2007
Tongue: English
Weight: 329 KB
Volume: 60
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-006-0411-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line panitumumab plus irinotecan/5

First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer

✍ Claus-Henning Köhne; Ralf Hofheinz; Laurent Mineur; Henry Letocha; Richard Greil 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 584 KB

Alpha-interferon in combination with 5-f

Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study

✍ C. J. A. Punt; P. H. M. Mulder; J. Th. M. Burghouts; D. J. Th. Wagener 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 331 KB

A multicenter phase II study of irinotec

A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer

✍ JuanJosé Reina; Jorge Aparicio; Javier Salvador; JoséMaríaPuerto Pica; Antonio R 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 192 KB

Simvastatin plus irinotecan, 5-fluoroura

Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study

✍ Jeeyun Lee; Kyung Hae Jung; Young Suk Park; Joong Bae Ahn; Sang Jun Shin; Seock- 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 284 KB

Tritherapy with fluorouracil/leucovorin,

Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases

✍ M. Ychou; F. Viret; A. Kramar; F. Desseigne; E. Mitry; R. Guimbaud; J. R. Delper 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 320 KB

A comprehensive review of 5-fluorouracil

A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma

✍ David Machover 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

## Background: Colorectal carcinoma is the third leading cause of cancer-related death. the primary treatment for patients with metastatic colorectal carcinoma is systemic chemotherapy with 5-fluorouracil (5-fu) and leucovorin (lv), a biomodulator of 5-fu that has been shown to enhance its activity